Derek Chalmers

2021

In 2021, Derek Chalmers earned a total compensation of $10.2M as Former President and Chief Executive Officer at Cara Therapeutics, a 250% increase compared to previous year.

Compensation breakdown

Option Awards$7,950,174
Salary$570,062
Stock Awards$1,665,680
Other$10,869
Total$10,196,785

Chalmers received $8M in option awards, accounting for 78% of the total pay in 2021.

Chalmers also received $570.1K in salary, $1.7M in stock awards and $10.9K in other compensation.

Rankings

In 2021, Derek Chalmers' compensation ranked 1,009th out of 12,415 executives tracked by ExecPay. In other words, Chalmers earned more than 91.9% of executives.

ClassificationRankingPercentile
All
1,009
out of 12,415
92nd
Division
Manufacturing
339
out of 5,505
94th
Major group
Chemicals And Allied Products
113
out of 2,375
95th
Industry group
Drugs
96
out of 2,096
95th
Industry
Pharmaceutical Preparations
64
out of 1,546
96th

Pay ratio

Derek Chalmers' Pay$10,196,785
Median Employee's Pay$192,240
Pay Ratio

53

to 1

In 2021, the annual total compensation of Derek Chalmers was $10,196,785.

The annual total compensation of the median employee at Cara Therapeutics was $192,240.

The ratio of Derek Chalmers' pay to the pay of median employee was therefore 53 to one.

Source: SEC filing on April 22, 2022.

Chalmers' colleagues

We found five more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2021.

2021

Christopher Posner

Cara Therapeutics

Chief Executive Officer

2021

Frédérique Menzaghi

Cara Therapeutics

Chief Scientific Officer

2021

Joana Goncalves

Cara Therapeutics

Chief Medical Officer

2021

Scott Terrillion

Cara Therapeutics

General Counsel

2021

Thomas Reilly

Cara Therapeutics

Chief Financial Officer

News

In-depth

You may also like